Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 33

Results For "Formulations"

460 News Found

Pfizer sets up global drug development centre in Chennai
News | May 04, 2022

Pfizer sets up global drug development centre in Chennai

The facility is among 12 centres established worldwide, and the first in Asia


Sona Group partners with Mycelium Biotechnology for R&D in Salem
Biotech | May 02, 2022

Sona Group partners with Mycelium Biotechnology for R&D in Salem

As a global mushroom biotechnology group, Mycelium Biotechnology is engaged in mushroom growing, global distribution and offering biotechnology and nutraceutical solutions through global partners


India’s pharma exports grow by 103% since 2013-14
News | May 01, 2022

India’s pharma exports grow by 103% since 2013-14

Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions


Lupin and Yabao announce strategic partnership in China
News | April 27, 2022

Lupin and Yabao announce strategic partnership in China

The demand for high-quality paediatric medicines has been growing rapidly in China as a result of the government’s support and policy measures


Malaysia awards three-year contract for Biocon Biologics’ Insugen
Biotech | April 26, 2022

Malaysia awards three-year contract for Biocon Biologics’ Insugen

Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics


Glenmark is the first to launch Teneligliptin and Pioglitazone Fixed-Dose Combination
News | April 25, 2022

Glenmark is the first to launch Teneligliptin and Pioglitazone Fixed-Dose Combination

The innovative Fixed-Dose Combination will help improving the glycemic control among adult patients with insulin resistance, those whose diabetes is uncontrolled by metformin; and also those who require addition of Teneliglitptin and Pioglitazone as separate drugs.


Shilpa Medicare receives NoC for biosimilar Aflibercept
Biotech | April 25, 2022

Shilpa Medicare receives NoC for biosimilar Aflibercept

Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab


Phase 1/2 clinical trial of Covid-19-Influenza combination vaccine show positive results
Biotech | April 21, 2022

Phase 1/2 clinical trial of Covid-19-Influenza combination vaccine show positive results

Immune response confirmed in stand-alone influenza vaccine and combination vaccine with a potential path forward for both


PM Narendra Modi lays down five goals for new WHO Global Centre
News | April 19, 2022

PM Narendra Modi lays down five goals for new WHO Global Centre

Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine


Geocann and Averix Bio to partner on API phytocannabinoid ingredients
News | April 18, 2022

Geocann and Averix Bio to partner on API phytocannabinoid ingredients

This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors